| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025355 |
| Receipt No. | R000029185 |
| Official scientific title of the study | Influence of oxidative components on a vascular function improvement effect of polyphenol. |
| Date of disclosure of the study information | 2016/12/21 |
| Last modified on | 2017/06/21 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Influence of oxidative components on a vascular function improvement effect of polyphenol. | |
| Title of the study (Brief title) | Influence of oxidative components on a vascular function improvement effect of polyphenol. | |
| Region |
|
|
| Condition | |||
| Condition | Healthy adult | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To confirm the effects of oxidative components on oxidative stress markers and vascular function. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Blood samples were collected before ingestion and at 0.5,1 and 2 hours after ingestion. FMD was measured before and 1, 2 and 4 hours after ingestion. Urine samples were collected before ingestion and accumulation urine samples were pooled during the postprandial periods for 2 and 4 hrs.
Primary outcomes are oxidative stress markers and vascular endothelial function. |
| Key secondary outcomes | Key secondary outcomes are blood glucose. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | A drink: The polyphenol drink containing an oxidization component.
B drink: The polyphenol drink which reduced the oxidization component by X treatment. C drink: The polyphenol drink which reduced the oxidization component by Y treatment. The subjects ingested a single intake of A drink, and ingested a single intake of B drink after 7 days, and also ingested a single intake of C drink after 7 days. |
|
| Interventions/Control_2 | The subjects ingested a single intake of B drink, and ingested a single intake of C drink after 7 days, and also ingested a single intake of A drink after 7 days. | |
| Interventions/Control_3 | The subjects ingested a single intake of C drink, and ingested a single intake of A drink after 7 days, and also ingested a single intake of B drink after 7 days. | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1) Subjects whose fasting blood glucose levels are ranged to less than 126mg/dL
2) Subjects whose HbA1c1 levels are ranged to less than 6.2% 3) Subjects whose BMI are from 18.5 Kg/m2 to less than 35 Kg/m2 4) Subjects who can make self-judgment and are voluntarily giving written informed consent |
|||
| Key exclusion criteria | 1) Subjects who take continuous medical treatment
2) Subjects who are contracting heart disease, liver disease, kidney disease, digestive disease and allergy disease 3) Subjects with smoking habit 4) Subjects who are not eligible due to physician's judgment |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Noriyasu Ota |
| Organization | Kao Coporation |
| Division name | R&B-Core Technology-Biological Science Research |
| Address | 2606,Akabane,Ichikai-Machi,Haga-Gun,Tochigi,321-3497,Japan |
| TEL | 0285-68-7828 |
| ota.noriyasu@kao.co.jp | |
| Public contact | |
| Name of contact person | Hiroko Jokura |
| Organization | Kao Coporation |
| Division name | R&B-Core Technology-Biological Science Research |
| Address | 2606,Akabane,Ichikai-Machi,Haga-Gun,Tochigi,321-3497,Japan |
| TEL | 0285-68-7164 |
| Homepage URL | |
| joukura.hiroko@kao.co.jp | |
| Sponsor | |
| Institute | Kao Coporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kao Coporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 花王株式会社生物科学研究所(栃木県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029185 |